Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Funding from the Azaylia Foundation will support the Scientific Advances for Infant Leukaemia (SAIL) programme.

An adult holds a baby's hand in theirs. © Hu Chen/Unsplash

Yesterday it was announced that the Azaylia Foundation have donated £101,850 to fund the Scientific Advances for Infant Leukaemia (SAIL) programme, a UK-wide collaboration between the University of Oxford's Department of Paediatrics and Great Ormond Street Hospital.

The programme prioritises the development of treatments tailored to childhood cancers. Researchers in the programme, including the Childhood Leukaemia Research Group from the MRC WIMM and MRC MHU, aim to create a roadmap for all types of leukaemia, and improve prognosis for patients with cancers such as acute lymphoblastic leukaemia (ALL).

Similar stories

MRC National Mouse Genetics Network Research Clusters Announced

Claus Nerlov and Steve Twigg from the MRC WIMM join the new national network for disease modelling.

From ‘Ew, gross!’ to ‘Wow!’: Scientists bring immunology to the classroom

For British Science Week, members of the MRC WIMM visited a local Oxfordshire primary school for an interactive science day – one of the first of its kind since the start of the pandemic.

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Study links the onset of circulation to changes in metabolism affecting blood stem cell development

A new paper published in Cell Reports by the de Bruijn Group indicates that the onset of circulation triggers a metabolic switch associated with the maturation of haematopoietic stem cells.

Mohsin Badat receives ASH-BSH Abstract Achievement Award

Dr Mohsin Badat, a Clinical Training Research Fellow from the Higgs and Davies Groups has been awarded the ASH-BSH Abstract Achievement Award by the American Society of Haematology and the British Society of Haematology.